Skip to main content

54 044 (Everolimus 0.75 mg)

Pill with imprint 54 044 is White, Round and has been identified as Everolimus 0.75 mg. It is supplied by Hikma Pharmaceuticals PLC.

Everolimus is used in the treatment of neuroendocrine carcinoma; breast cancer; organ transplant, rejection prophylaxis; pancreatic cancer; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 0.75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 044

Everolimus 0.75 mg 54 044

Everolimus

Imprint
54 044
Strength
0.75 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Mtor inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Hikma Pharmaceuticals PLC
Manufacturer
West-Ward Columbus Inc.
National Drug Code (NDC)
00054-0472

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.